About: Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. It also develops aritinercept, a dual inhibitor of B cell-activating factor and proliferation-inducing ligand for the potential treatment of autoimmune diseases. The company was founded in 1993 and is headquartered in Edmonton, Canada.
Sector: Healthcare
Industry: Biotechnology
Latest price: $16.25 (+1.12%)
AUPHNASDAQAurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc share price
AUPH price activity
Last Price
$16.250
Change (24hr)
0.18 USD (1.12%)
Volume
716.98K
Volume (4w avg)
-
Open
$15.97
Day Range
$15.85 - $16.31
Previous Close
$16.07
Last Trade
09 Sep, 8:00 pm GMT+0
Delayed
09 Sep, 8:00 pm GMT+0
AUPH price performance
Delayed
09 Sep, 8:00 pm GMT+0
AUPH Market Signals